Short-Chain Fatty Acid Analysis Service

In the rapidly evolving landscape of metabolic disease research, the gut microbiome has emerged as a central regulator of host energy homeostasis. Protheragen provides a specialized short-chain fatty acid (SCFA) analysis service specifically designed to accelerate the development of next-generation anti-obesity therapeutics.

Precision Short-Chain Fatty Acid Analysis for Anti-Obesity Therapeutics

Our preclinical analytical platform empowers researchers to quantify these volatile metabolites with unparalleled sensitivity. By integrating high-resolution metabolomics with deep biological insights, we help our partners decode how experimental compounds influence the gut-brain axis and metabolic inflammation, turning complex microbiome data into actionable leads for weight-management drug discovery.

Core Technologies

To overcome the inherent challenges of SCFA analysis—such as high volatility, low molecular weight, and matrix complexity—Protheragen utilizes a dual-platform approach:

Service Scope

Our SCFA analysis service covers a broad spectrum of metabolites and matrices essential for preclinical obesity research:

Inquire Today for a Customized Project Quote and Technical Consultation.

Workflow

Protheragen has streamlined the preclinical analytical process to ensure rapid turnaround without compromising scientific rigor.

Fields of Application

The identification of specific short-chain fatty acid profiles is a critical milestone in characterizing the efficacy of metabolic interventions and establishing the mechanistic bridge between gut microbial activity and systemic anti-obesity effects.

• GLP-1 Secretion Studies: Quantifying how SCFAs trigger enteroendocrine cells to release satiety hormones.
• Lipid Metabolism Research: Assessing the role of propionate in inhibiting hepatic lipogenesis.
• Anti-Inflammatory Screening: Monitoring butyrate-mediated suppression of low-grade systemic inflammation in adipose tissue.
• Dietary Intervention Trials: Evaluating the efficacy of prebiotics or high-fiber diets in animal models of obesity.

Advantages

Choosing Protheragen means partnering with a leader in preclinical metabolic profiling. Our advantages include:

• Preclinical Specialization

Unlike general-purpose labs, our entire facility and workflow are architected specifically for animal model research. We move beyond basic serum analysis to provide deep, tissue-specific insights. Whether distinguishing between the metabolic signatures of brown adipose vs. white adipose tissue or analyzing site-specific gut segments, our assays are designed to capture metabolites in their true biological context, ensuring the data reflects actual physiological states.

• Unmatched Sensitivity

The systemic concentration of short-chain fatty acids (SCFAs) is often orders of magnitude lower than in the gut. Our platform achieves ultra-low detection limits (down to 0.1 µmol/L), enabling the quantification of circulating SCFAs that other labs miss. This precision is vital for researchers studying the gut-brain axis, specifically the distal effects of metabolites on the hypothalamus and other extra-intestinal targets.

• Strict Preclinical Focus

We maintain a strict preclinical focus, specializing exclusively in animal models and in vitro systems. This allows us to master the unique "matrix effects" inherent in rodent studies—such as the high lipid content in specific tissues or the small sample volumes available from neonatal mice. We don't apply human protocols to animal samples; we build bespoke pipelines optimized for the rigors of preclinical discovery.

• Exceptional Reproducibility

In drug development, the ability to detect subtle therapeutic shifts is paramount. Protheragen delivers industry-leading precision with a coefficient of variation (CV) consistently below 5%. This high level of reproducibility increases your study's statistical power, allowing you to achieve "p-value significance" with smaller cohorts and providing the confidence required for critical go/no-go decisions.

• Validated Preservation Protocols

The integrity of SCFA data is often compromised the moment a sample is collected. To combat this, we provide proprietary collection kits and stabilization protocols engineered to "freeze" the metabolic profile for up to 72 hours. By neutralizing enzymatic activity and preventing volatile metabolite loss, we eliminate the common pitfalls of degradation during transport, ensuring the samples arriving at our lab are an exact reflection of the point of collection.

Consult with Our Scientists to Design a Customized Workflow for Your Next Preclinical Study.

Publication Data

Customer Review

Frequently Asked Questions

1. Why is SCFA analysis critical for anti-obesity drug development?

   SCFAs are the functional link between the diet and host metabolism. Measuring them allows you to verify the mechanism of action of your drug if it targets the microbiome or its metabolites.

2. What is the minimum sample volume required?

   For fecal samples, we require approximately 50-100mg. For plasma/serum, we can achieve high-quality results with as little as 50µL.

3. How do you prevent the loss of volatile SCFAs during shipping?

   We provide specific guidelines for flash-freezing and shipping on dry ice. For certain projects, we provide stabilization buffers that "lock" the SCFAs in place at the time of collection.

4. Can you differentiate between branched-chain (BCFA) and straight-chain fatty acids?

   Yes, our GC-MS platform provides baseline separation between isomers like butyrate and isobutyrate, which is crucial as they originate from different fermentation pathways (carbohydrate vs. protein).

5. Do you provide services for human clinical trials?

   Protheragen focuses strictly on preclinical research. We do not provide clinical diagnostic services.

6. What is the standard turnaround time?

   Typically, QC-verified data is delivered within 10-15 business days following sample receipt.

7. Can we combine SCFA analysis with 16S rRNA sequencing?

   Absolutely. We often correlate metabolic profiles with microbial composition to provide a "multi-omic" view of your therapeutic's impact.

8. Do you assist with data interpretation for publication?

   Yes, our PhD scientists provide a summary report that interprets the findings in the context of current obesity literature.

Contact Us

Protheragen is dedicated to providing the high-resolution metabolic data required to bring innovative anti-obesity therapies to light. Our expertise in SCFA analysis ensures that your preclinical studies are built on a foundation of accuracy and scientific excellence.

Contact Protheragen for More Information and to Discuss Your Project.